ARCHIVES

WHI Investigators Reiterate: Breast Cancer, CHD Risks Too Great For Routine HT Use

This article is from The Cancer Letter archive.

Vol. 28 No. 40 | November 2, 2002

Download PDF Visit The Full Archive

Related Articles

GSK’s Votrient Approved For Advanced Kidney Cancer

October 30, 2009

In Brief: AC Committee Picks Seffrin for Executive VP; Charles Wilson Names to NCAB; 5 Leave Board

May 15, 1992

Experts Claim Errors in Breast Cancer Study, Demand Retraction of Practice-Changing Paper

May 18, 2012

Adriamycin Fact Sheet Available

July 4, 1975

NCI Names Brawly Director of Office of Special Populations

June 21, 1996

Appropriations: NIH Professional Needs Budget Gains Attention

March 14, 1997